Logo
x

Search

Subscribe Now

All Posts by Date

Janssen's Darzalex (daratumumab) in Combination with Lenalidomide + Dexamethasone Receive FDA's Approval for Transplant Ineligible Patients with Multiple Myeloma

Janssen's Darzalex (daratumumab) in Combination with Lenalidomide + Dexamethasone Receive FDA's Approval for Transplant Ineligible...

  • June 28, 2019
Alexion's Soliris (eculizumab) Receives FDA's Approval for Anti-Aquaporin-4 Antibody Positive Patients with Neuromyelitis Optica Spectrum Disorder

Alexion's Soliris (eculizumab) Receives FDA's Approval for Anti-Aquaporin-4 Antibody Positive Patients with Neuromyelitis Optica S...

  • June 28, 2019
Apple Disrupting the Healthcare with the Availability of One Drop Blood Glucose Monitor at its Retails Outlets in the US

Apple Disrupting the Healthcare with the Availability of One Drop Blood Glucose Monitor at its Retails Outlets in the US

  • June 28, 2019
Sanofi and Regeneron's Dupixent (dupilumab) Receive CHMP's Positive Opinion for Moderate-To-Severe Atopic Dermatitis in Adolescents

Sanofi and Regeneron's Dupixent (dupilumab) Receive CHMP's Positive Opinion for Moderate-To-Severe Atopic Dermatitis in Adolescent...

  • June 28, 2019
Innovent and Eli Lilly Report NMPA's Acceptance of NDA for IBI301 (rituximab- biosimilar) for Non-Hodgkin's lymphoma

Innovent and Eli Lilly Report NMPA's Acceptance of NDA for IBI301 (rituximab- biosimilar) for Non-Hodgkin's lymphoma

  • June 28, 2019
Pfizer's Zirabev (biosimilar- bevacizumab) Receives the US FDA's Approval for Five Types of Cancer

Pfizer's Zirabev (biosimilar- bevacizumab) Receives the US FDA's Approval for Five Types of Cancer

  • June 28, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.